Biotech's boom is headed up.
Cash fueling the growth of life sciences startups and maturing companies also is backing construction of speculative campuses — but instead of going horizontal with their buildings, Bay Area biotech real estate developers are increasingly heading vertical.
Wareham Development last week topped its seven-level, 260,000-square-foot EmeryStation West in Emeryville, and BioMed Realty broke ground earlier this month on the 550,000-square-foot first phase of its Gateway…
Biotech's boom is headed up.
Cash fueling the growth of life sciences startups and maturing companies also is backing construction of speculative campuses — but instead of going horizontal with their buildings, Bay Area biotech real estate developers are increasingly heading vertical.
Wareham Development last week topped its seven-level, 260,000-square-foot EmeryStation West in Emeryville, and BioMed Realty broke ground earlier this month on the 550,000-square-foot first phase of its Gateway…